Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Novel transcript, antisense to Nitric oxide synthase 1 adaptor protein
- Molecular classification
- Long non-coding RNA
01
Overview
This molecule is a naturally occurring, long non-coding RNA (lncRNA) transcribed antisense to the Nitric oxide synthase 1 adaptor protein (NOS1AP) gene. Natural antisense transcripts (NATs) like this are widespread and can modulate the expression of their sense (protein-coding) partners by various mechanisms, including transcriptional interference, RNA masking, and epigenetic modification of chromatin. The specific biological impact and clinical significance of this particular antisense transcript are not well characterized. There is currently no evidence that this RNA functions as a conventional therapeutic target such as a receptor or enzyme. Its major relevance is as a putative regulatory RNA, with possible implications for fine-tuning NOS1AP gene expression or chromatin state in specific contexts.
- Other names
- ENSG00000285636
02
Mechanism of action
Transcriptional interference, RNA masking, dsRNA-dependent RNA interference, chromatin remodeling (these are the main mechanisms characterized for natural antisense transcripts; no evidence for drug targeting)
03
Biological functions
Regulation of gene expression (specifically, may modulate expression or activity of NOS1AP through natural antisense mechanisms)
04
Disease associations
Other (potentially regulatory roles relevant to diseases involving NOS1AP such as nephrotic syndrome, Long QT syndrome, but no direct evidence for this transcript)
Beyond the preview
Go deeper on Novel transcript, antisense to Nitric oxide synthase 1 adaptor protein.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Novel transcript, antisense to Nitric oxide synthase 1 adaptor protein.